supplemented with 10 % heat inactivated fetal calf serum (v/v) (FCS,
Sigma-Aldrich, USA) and 1 % antibiotic/antimycotic solution (Capricorn
Scientific, Germany) (HTR medium). HUVEC were isolated from umbilical cords (5 individual
cases) collected after term deliveries (approved by the Ethical committee of the Clinical
Centre of Serbia, approval no. 57/10) by sequential short trypsinization as
previously described (Jiménez et al, 2013[18 (link)]). Collected cells were seeded on 0.2 % gelatin-coated plates and
maintained in M199 medium (Lonza, Belgium) supplemented with 20 % heat inactivated
FCS, 2 mM L-Glutamine (Torlak, Serbia), 0.4 % endothelial cell growth supplement
containing heparin (ECGS/H) (PromoCell GmbH, Germany) and 1 %
antibiotic/antimycotic solution (HUVEC medium).